Medicare is negotiating prices for 15 targeted drugs, including those for conditions such as hiv and arthritis, as well as popular medications like botox and trulicity. The list of drugs includes some from new jersey pharmaceutical companies. The development is part of a larger effort to address drug pricing, although some reports suggest that previous agreements have not prevented price increases.